Kanmin Xue
Papers
5
Total Citations
313
H-Index
4
About
Kanmin Xue is a pioneering ophthalmologist and surgical innovator whose research sits at the cutting edge of robotic retinal surgery. Based at the University of Oxford, Xue has dedicated his career to transcending the physiological limitations of human-performed eye surgery, developing robotic systems capable of achieving unprecedented precision within the delicate confines of the human eye. Xue's most celebrated contribution is his leadership of the world's first-in-human intraocular robotic surgery trial, published in 2018 and now accumulating over 215 citations — a landmark achievement that demonstrated both the safety and viability of robot-assisted procedures inside the living eye. Building on this breakthrough, he subsequently led the first-in-human robot-assisted subretinal drug delivery under local anesthesia, opening transformative possibilities for treating conditions such as age-related macular degeneration. Through systematic reviews and clinical evaluations, Xue has also worked to rigorously assess the broader practicality of ophthalmic robotics, helping to establish an evidence base for this emerging field. His body of work represents a paradigm shift in vitreoretinal surgery, demonstrating that robotic assistance can meaningfully expand the surgical repertoire, improve patient outcomes, and bring previously impossible procedures within clinical reach.
Research Focus
Key Achievements
Top Papers
- 1First-in-human study of the safety and viability of intraocular robotic surgery215 citations · 2018
- 2
- 3Robot-Assisted Retinal Surgery: Overcoming Human Limitations15 citations · 2019
- 4
- 5